Measure of glycosylated hemoglobin

Acta Biomedica de l'Ateneo Parmense

Volumn 76, Issue SUPPL. 3, 2005, Pages 59-62

  Calisti, Lorenza ^a   Tognetti, Simona ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Diabetes; Glycemic control; Glycosylated hemoglobin; Glycosylation

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN VARIANT;

CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; LEUKOCYTE COUNT; METABOLIC REGULATION; PROTEIN GLYCOSYLATION; RISK ASSESSMENT; UREMIA; ARTICLE; ARTIFACT; BLOOD; CALIBRATION; CHEMISTRY; IMMUNOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; ION EXCHANGE CHROMATOGRAPHY; LABORATORY DIAGNOSIS; POSTPRANDIAL STATE; REPRODUCIBILITY; STANDARD;

ARTIFACTS; BIOLOGICAL MARKERS; CALIBRATION; CHROMATOGRAPHY, ION EXCHANGE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS, ABNORMAL; HUMANS; IMMUNOCHEMISTRY; POSTPRANDIAL PERIOD; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 33750137643     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Dahl-Jorghensen K, Brichmann-Hanssen O, Hansenn KF, et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy. The Oslo Study. Br Med J 1986; 293: 1195-9.
2. Lauritzen T, Forst-Larsen K, Larsen HV, Deckert T. Steno Study group: Two-year experience with continuous subcutaneus infusion in relation to retinopathy and nephrophaty. Diabetes 1985; 34 (suppl. 3): 74-9.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of Diabetes on the development and progression of long term complications in the diabetes control in insulin diabetes mellitus. N Engl J Med 1993; 329: 977-86.
4. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21.
5. Brownlee M, Cerami A, Vlassara H. Advanced products glycosilation and the pathogenesis of diabetic vascular disease. Diabetes/Metabolism Reviews 1988; 4: 437-51.
6. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochimical basis of diabetic complications. N Engl J Med 1988; 318: 1315.
7. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosyl protein. An index of diabetic control. Clin Chim Acta 1982; 127: 87-95.
8. Mosca A, Lapolla A, Franzini C. La determinazione della emoglobina glicata (HbA1c) nel sangue: raccomandazioni. Biochim Clin 2000; 24: 183-7.
9. Little RR, et al. The National glycoemoglobin standardization program: a five year progress report. Clin Chem 2001; 47: 1985-992.
10. NGSP SteeringCommettee: Implementation of the National Glycohemoglobin standardization Program (NGSP). Diabetes 1997; 46 (Suppl.1): 151A.
11. Mosca A, Paleari R. Standardizzazione dell'emoglobina glicata rapporto sugli ultimi tre anni di attività. Biochim Clin 1998; 22: 645-9.
12. Wwwglicata.org
13. Roberts WL, McCraw M, Cook CB. Effects of sickle cell trait and hemoglobin C trait on determinations of HbA1c by an immunoassay method. Diabetes Care 21: 983-6.
14. Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care 23: 339-44.
15. Schifreen RS, Hickingbotham JM, Bowers GN. Accuracy, precision and stability in measurement of hemoglobin A1c by high performance cation exchange chromatography. Clin Chem 1980; 26: 3-8.
16. Matteucci E, Milioni C, Biasci E, Bertoni C, Boldrini E, Giampiero O. With regard to glycohemoglobin measurement: are we sure that high-performance liquid chromathography currently works in the clinical routine? Acta Diabetologica 1998; 35: 41-7.
17. Vanelli M, De Fanti A, Avantaggiato S, et al. Performance e utilità di un metodo immunologico rapido per il dosaggio dell'HbA1c nell'ambulatorio diabetologico. Minerva Pediatrica 1993; 45: 373-7.
18. Marrero DG, Vandagriff JL, Fineberg SE, Fineberg NS, Hiar CE, Crowley LE. Immediate HbA1c Results: Performane of the new HbA1c system in pediatric outpatient population. Diabetes Care 1992; 15: 1045-8.
19. Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF, Gallop PM. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977; 44: 859-64.
20. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lerman M, Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 1976; 295k: 417-20.
21. Bun FH. Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 1981; 30: 613-7.
22. Gillery P, Dumont G, Vassault A. Evaluation of GHb assays in France by national qualit urveys y controls. Diabetes Care 21: 265-70.
23. Goldstein DE, Peth SB, England JD, et al. Effects of acute changes in blood glucoseOn HbA1c. Diabetes 1980; 29: 623-8.
24. Rohlfing CL, Wiedmeyer H-M, Little RR, England JD, Tennill A, Goldstein DE. Defining the Relationship Between Plasma Glucose and HbA1c: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 25: 275-8.
25. Rose E, Ketchell MLS. Does daily monitoring of blood glucose predict hemoglobinaA1c levels? J Fam Pract 2003; 52: 485-90.
26. Monnier L, Lapinski H, Claude C. Contributions of fasting and postprandial plasma glucose Increments to the overall diurnal hyperglicemia of Type 2 diabetic patients. Variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-5.